Literature DB >> 16922635

Caco-2 cell permeability assays to measure drug absorption.

Richard B van Breemen1, Yongmei Li.   

Abstract

Caco-2 cells are a human colon epithelial cancer cell line used as a model of human intestinal absorption of drugs and other compounds. When cultured as a monolayer, Caco-2 cells differentiate to form tight junctions between cells to serve as a model of paracellular movement of compounds across the monolayer. In addition, Caco-2 cells express transporter proteins, efflux proteins, and Phase II conjugation enzymes to model a variety of transcellular pathways as well as metabolic transformation of test substances. In many respects, the Caco-2 cell monolayer mimics the human intestinal epithelium. One of the functional differences between normal cells and Caco-2 cells is the lack of expression of the cytochrome P450 isozymes and in particular, CYP3A4, which is normally expressed at high levels in the intestine. However, Caco-2 cells may be induced to express higher levels of CYP3A4 by treatment with vitamin D3. Caco-2 cell monolayers are usually cultured on semipermeable plastic supports that may be fitted into the wells of multi-well culture plates. Test compounds are then added to either the apical or basolateral sides of the monolayer. After incubation for various lengths of time, aliquots of the buffer in opposite chambers are removed for the determination of the concentration of test compounds and the computation of the rates of permeability for each compound (called the apparent permeability coefficients). Although radiolabelled compounds were used in the original Caco-2 cells monolayer assays, radiolabelled compounds have been replaced in most laboratories by the use of liquid chromatography-mass spectrometry (LC-MS) and LC-tandem mass spectrometry (LC-MS-MS). Mass spectrometry not only eliminates the need for radiolabelled compounds, but permits the simultaneous measurement of multiple compounds. The measurement of multiple compounds per assay reduces the number of incubations that need to be carried out, thereby increasing the throughput of the experiments. Furthermore, LC-MS and LC-MS-MS add another dimension to Caco-2 assays by facilitating the investigation of the metabolism of compounds by Caco-2 cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16922635     DOI: 10.1517/17425255.1.2.175

Source DB:  PubMed          Journal:  Expert Opin Drug Metab Toxicol        ISSN: 1742-5255            Impact factor:   4.481


  90 in total

Review 1.  Modeling kinetics of subcellular disposition of chemicals.

Authors:  Stefan Balaz
Journal:  Chem Rev       Date:  2009-05       Impact factor: 60.622

2.  Preclinical Evaluation of Acylhydrazone SB-AF-1002 as a Novel Broad-Spectrum Antifungal Agent.

Authors:  Cristina Lazzarini; Krupanandan Haranahalli; J Brian McCarthy; John Mallamo; Iwao Ojima; Maurizio Del Poeta
Journal:  Antimicrob Agents Chemother       Date:  2020-08-20       Impact factor: 5.191

3.  Discovery, synthesis, and biological evaluation of novel SMN protein modulators.

Authors:  Jingbo Xiao; Juan J Marugan; Wei Zheng; Steve Titus; Noel Southall; Jonathan J Cherry; Matthew Evans; Elliot J Androphy; Christopher P Austin
Journal:  J Med Chem       Date:  2011-08-19       Impact factor: 7.446

4.  Effect of five novel 5-substituted tetrandrine derivatives on P-glycoprotein-mediated inhibition and transport in Caco-2 cells.

Authors:  Zhonglian Cao; Dan Li; Li Liu; Ping Yang
Journal:  Oncol Lett       Date:  2018-09-24       Impact factor: 2.967

5.  Assessment of In Vivo Clinical Product Performance of a Weak Basic Drug by Integration of In Vitro Dissolution Tests and Physiologically Based Absorption Modeling.

Authors:  Xuan Ding; Ivelina Gueorguieva; James A Wesley; Lee J Burns; Carrie A Coutant
Journal:  AAPS J       Date:  2015-07-01       Impact factor: 4.009

6.  Discovery and structure-based optimization of adenain inhibitors.

Authors:  Aengus Mac Sweeney; Philipp Grosche; David Ellis; Keith Combrink; Paul Erbel; Nicola Hughes; Finton Sirockin; Samu Melkko; Anna Bernardi; Paul Ramage; Nadine Jarousse; Eva Altmann
Journal:  ACS Med Chem Lett       Date:  2014-06-20       Impact factor: 4.345

Review 7.  Nitric oxide synthase and structure-based inhibitor design.

Authors:  Thomas L Poulos; Huiying Li
Journal:  Nitric Oxide       Date:  2016-11-23       Impact factor: 4.427

Review 8.  The "Leaky Gut": Tight Junctions but Loose Associations?

Authors:  Daniel Hollander; Jonathan D Kaunitz
Journal:  Dig Dis Sci       Date:  2020-05       Impact factor: 3.199

Review 9.  Back to the future: can physical models of passive membrane permeability help reduce drug candidate attrition and move us beyond QSPR?

Authors:  Robert V Swift; Rommie E Amaro
Journal:  Chem Biol Drug Des       Date:  2013-01       Impact factor: 2.817

10.  Absorption and metabolism of the mycotoxins alternariol and alternariol-9-methyl ether in Caco-2 cells in vitro.

Authors:  Britta Burkhardt; Erika Pfeiffer; Manfred Metzler
Journal:  Mycotoxin Res       Date:  2009-09-09       Impact factor: 3.833

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.